Non-pharmacological interventions for sleep promotion in hospitalized children

Sapna R Kudchadkar1,2,3, Jessica Berger1, Ruchit Patel1

  • 1Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Insights

Non-pharmacological interventions for hospitalized children show inconsistent results on sleep quality. More research is needed to determine their effectiveness in improving sleep duration and overall outcomes for pediatric patients.

Area of Science:

  • Pediatric Sleep Medicine
  • Child Development
  • Neurologic Maturation

Background:

  • Healthy sleep is crucial for childhood development and neurologic maturation.
  • Hospitalization can disrupt sleep, negatively impacting brain development during illness and recovery.
  • Non-pharmacological interventions are important for promoting sleep in pediatric inpatients.

Purpose of the Study:

  • To evaluate non-pharmacological sleep promotion interventions in hospitalized children and adolescents.
  • Assess impact on sleep quality, duration, satisfaction, cost-effectiveness, delirium, ventilation, length of stay, and mortality.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) and quasi-RCTs.
  • Included children aged 1 month to 18 years in inpatient pediatric settings.
  • Assessed interventions for sleep quality and duration, with secondary outcomes including satisfaction and clinical measures.

Main Results:

  • Included 10 trials with 528 participants; substantial heterogeneity prevented quantitative synthesis.
  • Behavioral interventions (e.g., massage, bedtime stories) showed low to very low-certainty evidence of no clear difference or inconsistent effects on sleep.
  • Physical activity interventions also yielded low-certainty evidence with little or no improvement in sleep.

Conclusions:

  • Evidence on non-pharmacological sleep promotion interventions in pediatric inpatients is inconsistent and of low to very low certainty.
  • Unable to definitively determine the effectiveness of these interventions on sleep quality or duration.
  • Further high-quality RCTs using validated objective sleep measures are recommended to strengthen the evidence base.
Abstract

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
319
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
210
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
236
Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
123
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
629
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
216